Treatment of gestational diabetes before 20 weeks' gestation improves neonatal outcomes
1. In this randomized controlled trial, the treatment of gestational diabetes before 20 weeks' gestation was associated with a lower risk of adverse neonatal outcomes compared to no treatment. 2. There was no significant difference between treatment and no treatment with respect to maternal hypertension or neonatal lean body mass. Evidence Rating Level: 1 (Excellent)